USPTO trademark

VIA LINX

Awaiting publicationUSPTOWord markClass 5Class 10

"VIA LINX" is a word mark owned by Vivex Biologics Group, Inc., filed at the USPTO on April 24, 2026. It is waiting to be published and covers classes 5 and 10.

Get this data via the API
Official USPTO record
VIA LINX trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 22, 2026
Filed
April 24, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99784524
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns VIA LINX

The owner and representative on file with the office.

Owner

Vivex Biologics Group, Inc.

Miami, United States

Representative

Olivia Maria Baratta

Kilpatrick Townsend & Stockton LLP

Goods and services

What the mark covers

The products and services VIA LINX is filed for, grouped by Nice class.

  • Synthetic peptides for the treatment of wounds; peptides to manage, stop or prevent the undesirable movement in or on the body, of blood, inflammatory cells, bacteria, and contaminants, and for the treatment of wounds and bleeding or leaking tissue and blood vessels

  • Medical devices for closing wounds; medical devices, namely, devices for measuring wounds; medical devices for use in treating wounds

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Teas/email correspondence entered
  3. Correspondence received in law office
  4. Teas response to office action received
  5. Notification of non-final action e-mailed
  6. Non-final action e-mailed
  7. Non-final action written
  8. Assigned to examiner
  9. New application office supplied data entered
  10. Application filing receipt mailed

1 earlier step on the official record.

FAQ

About VIA LINX

Who owns the trademark "VIA LINX"?

The USPTO trademark "VIA LINX" (application 99784524) is owned by Vivex Biologics Group, Inc.

What is the status of "VIA LINX"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VIA LINX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019dcc8e-2a6b-76eb-b42a-aca6403ecb73
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019dcc8e-2a6b-76eb-b42a-aca6403ecb73",
  "object": "trademark",
  "mark_text": "VIA LINX",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "99784524",
  "filing_date": "2026-04-24",
  "nice_classes": [
    5,
    10
  ],
  "owners": [
    {
      "name": "Vivex Biologics Group, Inc.",
      "entity_id": null
    }
  ]
}